| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10.327 | 65.097 | 43.274 | 22.757 | - | - | - |
| Total Income - EUR | - | - | - | 10.327 | 65.104 | 43.274 | 22.757 | - | - | - |
| Total Expenses - EUR | - | - | - | 36 | 14.046 | 5.450 | 578 | - | - | - |
| Gross Profit/Loss - EUR | - | - | - | 10.291 | 51.058 | 37.824 | 22.179 | - | - | - |
| Net Profit/Loss - EUR | - | - | - | 9.982 | 50.407 | 36.526 | 21.496 | - | - | - |
| Employees | - | - | - | 0 | 1 | 1 | 1 | - | - | - |
Check the financial reports for the company - Parssian Avicena Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 131 | 36.481 | 35.789 | 34.995 | - | - | - |
| Current Assets | - | - | - | 10.203 | 61.906 | 95.738 | 115.725 | - | - | - |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | - | - | - | 0 | 58.162 | 91.117 | 89.330 | - | - | - |
| Cash | - | - | - | 10.203 | 3.745 | 4.620 | 26.395 | - | - | - |
| Shareholders Funds | - | - | - | 10.024 | 60.237 | 95.621 | 114.997 | - | - | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | - | - | - |
| Debts | - | - | - | 310 | 38.150 | 35.905 | 35.723 | - | - | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Parssian Avicena Medical S.r.l.